Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Although deep networks have been shown to perform very well on a variety of medical imaging tasks, inference in the presence of pathology presents several challenges to common models. These challenges impede the integration of deep learning models into real clinical workflows, where the customary process of cascading deterministic outputs from a sequence of image-based inference steps (e.g. regist...
BACKGROUND AND PURPOSE: Diagnostic-quality amyloid PET images can be created with deep learning using actual ultra-low-dose PET images and simultaneous structural MR imaging. Here, we investigated whether simultaneity is required; if not, MR imaging-assisted ultra-low-dose PET imaging could be performed with separate PET/CT and MR imaging acquisitions.
Five fluorescent positively charged poly(-aryleneethynylene) (-) were designed to construct electrostatic complexes - with negatively charged graphene...
Assistive technology (AT) with context-aware computing and artificial intelligence capabilities can be applied to address cognitive and communication ...
Alzheimer's disease (AD) is the leading cause of age-related dementia, affecting over 5 million people in the United States and incurring a substantia...
Alzheimer's disease (AD) is the most generally known neurodegenerative disorder, leading to a steady deterioration in cognitive ability. Deep learning...
PURPOSE: To compare two artificial intelligence software packages performing normative brain volumetry and explore whether they could differently impa...
Initial development of artificial Intelligence (AI) and machine learning (ML) dates back to the mid-twentieth century. A growing awareness of the pote...
In a recent article from Cell Reports Medicine, Kwak et al. generate novel insights about subtyping cognitively impaired individuals based on structur...
BACKGROUND: Several studies have reported changes in the corpus callosum (CC) in Alzheimer's disease. However, the involved region differed according ...
Trajectories of cognitive decline vary considerably among individuals with mild cognitive impairment (MCI). To address this heterogeneity, subtyping a...
Abnormal tau inclusions are hallmarks of Alzheimer's disease and predictors of clinical decline. Several tau PET tracers are available for neurodegene...
. Alzheimer's disease (AD), a common disease of the elderly with unknown etiology, has been adversely affecting many people, especially with the aging...
BACKGROUND: Alzheimer's disease (AD) is a highly heterogeneous disease with diverse trajectories and outcomes observed in clinical populations. Unders...
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We describe and validate Smile-GAN (SeMI-supervised cLustEring-Gener...
IMPORTANCE: Machine learning algorithms could be used as the basis for clinical decision-making aids to enhance clinical practice.
Adequate blood supply is critical for normal brain function. Brain vasculature dysfunctions, including stalled blood flow in cerebral capillaries, are...
We designed a robotic architecture system within a commercially available socially assistive robot to engage pairs of older adults in multimodal activ...
AIM: This study aims to test the feasibility of the PainChek app to assess pain for people with dementia living in residential aged care facilities (R...
Ageing is associated with various ailments including Alzheimer 's disease (AD), which is a progressive form of dementia. AD symptoms develop over a pe...